93 related articles for article (PubMed ID: 8060138)
1. [Effects of 5'-DFUR against BALB/c retroperitoneal sarcoma with spontaneous liver metastases].
Fujii Y; Itoyanagi H; Saegusa Y; Hasumi K; Eriguchi M
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1627-31. PubMed ID: 8060138
[TBL] [Abstract][Full Text] [Related]
2. [Effects of HCFU and TNP 470 on liver metastasis of BALB/c retroperitoneal sarcoma (LMFS)].
Fujii Y; Iwasa H; Hirai J; Hasumi K; Eriguchi M
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2061-7. PubMed ID: 10584572
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of spontaneous liver metastatic model of BALB/c retroperitoneal sarcoma (LMFS) injected in footpad and antitumor effects of HCFU].
Fujii Y; Itoyanagi H; Hirose I; Hasumi K; Eriguchi M
Gan To Kagaku Ryoho; 1997 Feb; 24(3):343-8. PubMed ID: 9051138
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001).
Fujii Y; Iwasa H; Hirai J; Takahama Y; Hasumi K; Eriguchi M
Biomed Pharmacother; 2000 Mar; 54(2):85-92. PubMed ID: 10759292
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of BALB/c retroperitoneal sarcoma with spontaneous liver metastases.
Fujii Y; Itoyanagi H; Saegusa Y; Kuro-o M; Matsuda Y; Shiroko Y; Eriguchi M; Hasumi K
Jpn J Cancer Res; 1993 Oct; 84(10):1055-61. PubMed ID: 8226280
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis].
Kuroki Y; Yamashita I; Okamoto M; Ochiai H; Kurokawa M; Tazawa K; Fujimaki M
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1297-302. PubMed ID: 1829881
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Miwa M; Eda H; Fukuda H; Fujimoto K; Ishitsuka H
Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose.
Tazawa K; Sakamoto T; Kuroki Y; Yamashita I; Okamoto M; Katuyama S; Fujimaki M
Clin Exp Metastasis; 1997 May; 15(3):266-71. PubMed ID: 9174128
[TBL] [Abstract][Full Text] [Related]
10. Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
Hiraga T; Hata K; Ikeda F; Kitagaki J; Fujimoto-Ouchi K; Tanaka Y; Yoneda T
Oncol Rep; 2005 Sep; 14(3):695-9. PubMed ID: 16077977
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor activity of various cytostatics in mice bearing murine advanced tumors].
Fujimoto-Ouchi K; Tamura S; Mori K; Ishikawa T; Eda H; Tanaka Y; Ninomiya Y; Ishitsuka H
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2361-7. PubMed ID: 8259852
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
[TBL] [Abstract][Full Text] [Related]
13. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
[TBL] [Abstract][Full Text] [Related]
14. [5'-DFUR (doxifluridine)].
Taguchi T
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2235-43. PubMed ID: 2955744
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study relating to the anti-cancer effect of doxifluridine].
Zhao L; Kaneda T; Tohnai I; Shinoda T; Kasuya Y; Matsuyama M
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1182-9. PubMed ID: 2144562
[TBL] [Abstract][Full Text] [Related]
16. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Braun JM; Ko HL; Schierholz JM; Beuth J
Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
Iigo M; Miwa M; De Clercq E
Jpn J Cancer Res; 1990 Apr; 81(4):431-5. PubMed ID: 2142152
[TBL] [Abstract][Full Text] [Related]
18. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
19. [A case of recurrent colon cancer treated markedly effective with 5'-DFUR].
Hirano M; Kato A; Murakami N; Saito H; Watanabe S; Oosawa T; Kikkawa H; Kitagawa K; Masuda S; Mori H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1063-6. PubMed ID: 8512335
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
